Recruiting now
-
SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
Phase 2 · 24 people · 1 site in Canada · Recruiting now
-
SCRT + Fruquintinib + Tislelizumab + CAPOX Versus SCRT + Tislelizumab + CAPOX as Neoadjuvant Therapy for Locally Advanced Low Rectal Cancer
Phase 2 · randomised · 50 people · 1 site in China · Recruiting now
-
NeoCSR-Omics Trial: CAPOX + Serplulimab Before vs. After Short-course RT in LARC
Phase 2 · randomised · 100 people · 1 site in China · Recruiting now
-
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Phase 2 · randomised · 100 people · 30 sites in 6 countries · Recruiting now
-
Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer
Phase 3 · randomised · 394 people · 20 sites in Netherlands · Recruiting now